Global Pharmacokinetics Services Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pharmacokinetics Services market report explains the definition, types, applications, major countries, and major players of the Pharmacokinetics Services market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Shanghai Medicilon Inc (China)

    • Pharmaceutical Product Development, LLC (US)

    • Evotec AG (Germany)

    • Frontage Labs (US)

    • LGC Limited (UK)

    • SGS SA (Switzerland)

    • Creative Bioarray (US)

    • Certara, LP (Germany)

    • PAREXEL International Corporation (US)

    • Charles River Laboratories International Inc (US)

    • Pacific BioLabs (US)

    • GVK Biosciences Private Limited (India)

    • Eurofins Scientific Inc (Luxembourg)

    By Type:

    • Small Molecules Pharmacokinetics Services

    • Large Molecules (Biopharmaceuticals) Pharmacokinetics Services

    By End-User:

    • Small & Medium Enterprise

    • Large Enterprise

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pharmacokinetics Services Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pharmacokinetics Services Outlook to 2028- Original Forecasts

    • 2.2 Pharmacokinetics Services Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pharmacokinetics Services Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pharmacokinetics Services Market- Recent Developments

    • 6.1 Pharmacokinetics Services Market News and Developments

    • 6.2 Pharmacokinetics Services Market Deals Landscape

    7 Pharmacokinetics Services Raw Materials and Cost Structure Analysis

    • 7.1 Pharmacokinetics Services Key Raw Materials

    • 7.2 Pharmacokinetics Services Price Trend of Key Raw Materials

    • 7.3 Pharmacokinetics Services Key Suppliers of Raw Materials

    • 7.4 Pharmacokinetics Services Market Concentration Rate of Raw Materials

    • 7.5 Pharmacokinetics Services Cost Structure Analysis

      • 7.5.1 Pharmacokinetics Services Raw Materials Analysis

      • 7.5.2 Pharmacokinetics Services Labor Cost Analysis

      • 7.5.3 Pharmacokinetics Services Manufacturing Expenses Analysis

    8 Global Pharmacokinetics Services Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pharmacokinetics Services Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pharmacokinetics Services Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pharmacokinetics Services Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmacokinetics Services Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Small Molecules Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmacokinetics Services Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Small & Medium Enterprise Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Large Enterprise Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pharmacokinetics Services Market Analysis and Outlook till 2022

    • 10.1 Global Pharmacokinetics Services Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pharmacokinetics Services Consumption (2017-2022)

      • 10.2.2 Canada Pharmacokinetics Services Consumption (2017-2022)

      • 10.2.3 Mexico Pharmacokinetics Services Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.2 UK Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.3 Spain Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.4 Belgium Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.5 France Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.6 Italy Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.7 Denmark Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.8 Finland Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.9 Norway Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.10 Sweden Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.11 Poland Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.12 Russia Pharmacokinetics Services Consumption (2017-2022)

      • 10.3.13 Turkey Pharmacokinetics Services Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.2 Japan Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.3 India Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.4 South Korea Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.5 Pakistan Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.6 Bangladesh Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.7 Indonesia Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.8 Thailand Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.9 Singapore Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.10 Malaysia Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.11 Philippines Pharmacokinetics Services Consumption (2017-2022)

      • 10.4.12 Vietnam Pharmacokinetics Services Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.2 Colombia Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.3 Chile Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.4 Argentina Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.5 Venezuela Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.6 Peru Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pharmacokinetics Services Consumption (2017-2022)

      • 10.5.8 Ecuador Pharmacokinetics Services Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pharmacokinetics Services Consumption (2017-2022)

      • 10.6.2 Kuwait Pharmacokinetics Services Consumption (2017-2022)

      • 10.6.3 Oman Pharmacokinetics Services Consumption (2017-2022)

      • 10.6.4 Qatar Pharmacokinetics Services Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pharmacokinetics Services Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pharmacokinetics Services Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pharmacokinetics Services Consumption (2017-2022)

      • 10.7.2 South Africa Pharmacokinetics Services Consumption (2017-2022)

      • 10.7.3 Egypt Pharmacokinetics Services Consumption (2017-2022)

      • 10.7.4 Algeria Pharmacokinetics Services Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pharmacokinetics Services Consumption (2017-2022)

      • 10.8.2 New Zealand Pharmacokinetics Services Consumption (2017-2022)

    11 Global Pharmacokinetics Services Competitive Analysis

    • 11.1 Shanghai Medicilon Inc (China)

      • 11.1.1 Shanghai Medicilon Inc (China) Company Details

      • 11.1.2 Shanghai Medicilon Inc (China) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Shanghai Medicilon Inc (China) Pharmacokinetics Services Main Business and Markets Served

      • 11.1.4 Shanghai Medicilon Inc (China) Pharmacokinetics Services Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pharmaceutical Product Development, LLC (US)

      • 11.2.1 Pharmaceutical Product Development, LLC (US) Company Details

      • 11.2.2 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.2.4 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Evotec AG (Germany)

      • 11.3.1 Evotec AG (Germany) Company Details

      • 11.3.2 Evotec AG (Germany) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Evotec AG (Germany) Pharmacokinetics Services Main Business and Markets Served

      • 11.3.4 Evotec AG (Germany) Pharmacokinetics Services Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Frontage Labs (US)

      • 11.4.1 Frontage Labs (US) Company Details

      • 11.4.2 Frontage Labs (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Frontage Labs (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.4.4 Frontage Labs (US) Pharmacokinetics Services Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 LGC Limited (UK)

      • 11.5.1 LGC Limited (UK) Company Details

      • 11.5.2 LGC Limited (UK) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 LGC Limited (UK) Pharmacokinetics Services Main Business and Markets Served

      • 11.5.4 LGC Limited (UK) Pharmacokinetics Services Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 SGS SA (Switzerland)

      • 11.6.1 SGS SA (Switzerland) Company Details

      • 11.6.2 SGS SA (Switzerland) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 SGS SA (Switzerland) Pharmacokinetics Services Main Business and Markets Served

      • 11.6.4 SGS SA (Switzerland) Pharmacokinetics Services Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Creative Bioarray (US)

      • 11.7.1 Creative Bioarray (US) Company Details

      • 11.7.2 Creative Bioarray (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Creative Bioarray (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.7.4 Creative Bioarray (US) Pharmacokinetics Services Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Certara, LP (Germany)

      • 11.8.1 Certara, LP (Germany) Company Details

      • 11.8.2 Certara, LP (Germany) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Certara, LP (Germany) Pharmacokinetics Services Main Business and Markets Served

      • 11.8.4 Certara, LP (Germany) Pharmacokinetics Services Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 PAREXEL International Corporation (US)

      • 11.9.1 PAREXEL International Corporation (US) Company Details

      • 11.9.2 PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 PAREXEL International Corporation (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.9.4 PAREXEL International Corporation (US) Pharmacokinetics Services Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Charles River Laboratories International Inc (US)

      • 11.10.1 Charles River Laboratories International Inc (US) Company Details

      • 11.10.2 Charles River Laboratories International Inc (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Charles River Laboratories International Inc (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.10.4 Charles River Laboratories International Inc (US) Pharmacokinetics Services Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Pacific BioLabs (US)

      • 11.11.1 Pacific BioLabs (US) Company Details

      • 11.11.2 Pacific BioLabs (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Pacific BioLabs (US) Pharmacokinetics Services Main Business and Markets Served

      • 11.11.4 Pacific BioLabs (US) Pharmacokinetics Services Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 GVK Biosciences Private Limited (India)

      • 11.12.1 GVK Biosciences Private Limited (India) Company Details

      • 11.12.2 GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Main Business and Markets Served

      • 11.12.4 GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Eurofins Scientific Inc (Luxembourg)

      • 11.13.1 Eurofins Scientific Inc (Luxembourg) Company Details

      • 11.13.2 Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Main Business and Markets Served

      • 11.13.4 Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Pharmacokinetics Services Market Outlook by Types and Applications to 2028

    • 12.1 Global Pharmacokinetics Services Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Small Molecules Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pharmacokinetics Services Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Small & Medium Enterprise Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Large Enterprise Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pharmacokinetics Services Market Analysis and Outlook to 2028

    • 13.1 Global Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.2 UK Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.5 France Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.3 India Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pharmacokinetics Services Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pharmacokinetics Services Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pharmacokinetics Services Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pharmacokinetics Services

    • Figure of Pharmacokinetics Services Picture

    • Table Global Pharmacokinetics Services Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pharmacokinetics Services Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Small Molecules Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Global Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Global Small & Medium Enterprise Consumption and Growth Rate (2017-2022)

    • Figure Global Large Enterprise Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacokinetics Services Consumption by Country (2017-2022)

    • Table North America Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure United States Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Canada Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure Germany Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure UK Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Spain Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure France Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Italy Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Finland Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Norway Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Poland Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Russia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table APAC Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure China Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure India Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table South America Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure Brazil Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Chile Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Peru Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table GCC Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure Bahrain Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Oman Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table Africa Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure Nigeria Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table Oceania Pharmacokinetics Services Consumption by Country (2017-2022)

    • Figure Australia Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pharmacokinetics Services Consumption and Growth Rate (2017-2022)

    • Table Shanghai Medicilon Inc (China) Company Details

    • Table Shanghai Medicilon Inc (China) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Medicilon Inc (China) Pharmacokinetics Services Main Business and Markets Served

    • Table Shanghai Medicilon Inc (China) Pharmacokinetics Services Product Portfolio

    • Table Pharmaceutical Product Development, LLC (US) Company Details

    • Table Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Main Business and Markets Served

    • Table Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Product Portfolio

    • Table Evotec AG (Germany) Company Details

    • Table Evotec AG (Germany) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Evotec AG (Germany) Pharmacokinetics Services Main Business and Markets Served

    • Table Evotec AG (Germany) Pharmacokinetics Services Product Portfolio

    • Table Frontage Labs (US) Company Details

    • Table Frontage Labs (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Frontage Labs (US) Pharmacokinetics Services Main Business and Markets Served

    • Table Frontage Labs (US) Pharmacokinetics Services Product Portfolio

    • Table LGC Limited (UK) Company Details

    • Table LGC Limited (UK) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table LGC Limited (UK) Pharmacokinetics Services Main Business and Markets Served

    • Table LGC Limited (UK) Pharmacokinetics Services Product Portfolio

    • Table SGS SA (Switzerland) Company Details

    • Table SGS SA (Switzerland) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table SGS SA (Switzerland) Pharmacokinetics Services Main Business and Markets Served

    • Table SGS SA (Switzerland) Pharmacokinetics Services Product Portfolio

    • Table Creative Bioarray (US) Company Details

    • Table Creative Bioarray (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Creative Bioarray (US) Pharmacokinetics Services Main Business and Markets Served

    • Table Creative Bioarray (US) Pharmacokinetics Services Product Portfolio

    • Table Certara, LP (Germany) Company Details

    • Table Certara, LP (Germany) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Certara, LP (Germany) Pharmacokinetics Services Main Business and Markets Served

    • Table Certara, LP (Germany) Pharmacokinetics Services Product Portfolio

    • Table PAREXEL International Corporation (US) Company Details

    • Table PAREXEL International Corporation (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table PAREXEL International Corporation (US) Pharmacokinetics Services Main Business and Markets Served

    • Table PAREXEL International Corporation (US) Pharmacokinetics Services Product Portfolio

    • Table Charles River Laboratories International Inc (US) Company Details

    • Table Charles River Laboratories International Inc (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Charles River Laboratories International Inc (US) Pharmacokinetics Services Main Business and Markets Served

    • Table Charles River Laboratories International Inc (US) Pharmacokinetics Services Product Portfolio

    • Table Pacific BioLabs (US) Company Details

    • Table Pacific BioLabs (US) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pacific BioLabs (US) Pharmacokinetics Services Main Business and Markets Served

    • Table Pacific BioLabs (US) Pharmacokinetics Services Product Portfolio

    • Table GVK Biosciences Private Limited (India) Company Details

    • Table GVK Biosciences Private Limited (India) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table GVK Biosciences Private Limited (India) Pharmacokinetics Services Main Business and Markets Served

    • Table GVK Biosciences Private Limited (India) Pharmacokinetics Services Product Portfolio

    • Table Eurofins Scientific Inc (Luxembourg) Company Details

    • Table Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Main Business and Markets Served

    • Table Eurofins Scientific Inc (Luxembourg) Pharmacokinetics Services Product Portfolio

    • Figure Global Small Molecules Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small & Medium Enterprise Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Large Enterprise Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Table North America Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure Germany Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure China Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pharmacokinetics Services Consumption Forecast by Country (2022-2028)

    • Figure Australia Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pharmacokinetics Services Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.